Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 7Kidney Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Clear-cell metastatic renal cell carcinoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Cystadenocarcinoma, Serous 1Colorectal Neoplasms 1Carcinosarcoma 1Carcinoma 1Breast Neoplasms 1Advanced Renal Cell Carcinoma (RCC) 1Adenocarcinoma, Mucinous 1

Interventions

toripalimab 1Axitinib 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Advanced Renal Cell Carcinoma (RCC) × Axitinib × Clear all
NCT07630363 2026-06-05

PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1/2 Not yet recruiting
40 enrolled
Genitourinary

Advanced Renal Cell Carcinoma (RCC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡